A comparative study to screen dementia and APOE genotypes in an ageing East African population

Neurobiology of Aging

Volumn 31, Issue 5, 2010, Pages 732-740

  Chen, Chien Hsiun ^a   Mizuno, Toshiki ^b   Elston, Robert ^a   Kariuki, Monica M ^c   Hall, Kathleen ^d   Unverzagt, Fred ^d   Hendrie, Hugh ^d   Gatere, Samuel ^e   Kioy, Paul ^f   Patel, Nilesh B ^f   Friedland, Robert P ^a   Kalaria, Raj N ^g  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KYOTO PREFECTURAL UNIVERSITY   (Japan)

^c Provincial General Hospital   (Kenya)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Avenue Hospital   (Kenya)

^f UNIVERSITY OF NAIROBI   (Kenya)

^g NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Africa; Alzheimer's disease; Apolipoprotein E; Cognitive impairment; Dementia; Kenya; Neuropsychology

Indexed keywords

APOLIPOPROTEIN E;

AFRICA; AGE DETERMINATION; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; KENYA; MAJOR CLINICAL STUDY; MALE; NIGERIA; POPULATION GENETICS; PRIORITY JOURNAL; RURAL POPULATION; SENSITIVITY AND SPECIFICITY;

AFRICA, EASTERN; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; AGING; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; DEMENTIA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENETICS, POPULATION; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PILOT PROJECTS; STATISTICS, NONPARAMETRIC;

EID: 77950532326     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.06.014     Document Type: Article

References (53)

1. Baiyewu O., Smith-Gamble V., Lane K.A., Gureje O., Gao S., Ogunniyi A., Unverzagt F.W., Hall K.S., Hendrie H.C. Prevalence estimates of depression in elderly community-dwelling African Americans in Indianapolis and Yoruba in Ibadan. Nigeria Int. Psychogeriatr. 2007, 19:679-689.
2. Borenstein A.R., Wu Y., Mortimer J.A., Schellenberg G.D., McCormick W.C., Bowen J.D., McCurry S., Larson E.B. Developmental and vascular risk factors for Alzheimer's disease. Neurobiol. Aging 2005, 26:325-334.
3. Bowirrat A., Friedland R.P., Farrer L., Baldwin C., Korczyn A. Genetic and environmental risk factors for Alzheimer's disease in Israeli Arabs. J. Mol. Neurosci. 2002, 19:239-245.
4. Brayne C. The EURODEM collaborative reanalysis of case-control studies of Alzheimer's disease: implications for public health. Int. J. Epidemiol. 1991, 20:568-571.
5. Buschke H., Kuslansky G., Katz M., Stewart W.F., Sliwinski M.J., Eckholdt H.M., Lipton R.B. Screening for dementia with the memory impairment screen. Neurology 1999, 52:231-238.
6. Corbo R.M., Scacchi R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele?. Ann. Hum. Genet. 1999, 63:301-310.
7. Corbo R.M., Scacchi R., Rickards O., Martinez-Labarga C., De Stefano G.F. An investigation of human apolipoproteins B and E polymorphisms in two African populations from Ethiopia and Benin. Am. J. Hum. Biol. 1999, 11:297-304.
8. Corbo R.M., Prevost M., Raussens V., Gambina G., Moretto G., Scacchi R. Structural and phylogenetic approaches to assess the significance of human Apolipoprotein E variation. Mol. Genet. Metab. 2006, 89:261-269.
9. Evans D.A., Funkenstein H.H., Albert M.S., Scherr P.A., Cook N.R., Chown M.J., Hebert L.E., Hennekens C.H., Taylor J.O. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 1989, 262:2551-2556.
10. Farrag A., Farwiz H.M., Khedr E.H., Mahfouz R.M., Omran S.M. Prevalence of Alzheimer's disease and other dementing disorders: Assiut-Upper Egypt study. Dement. Geriatr. Cogn. Disord. 1998, 9:323-328.
11. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997, 278:1349-1356.
12. Farrer L.A., Friedland R.P., Bowirrat A., Waraska K., Korczyn A., Baldwin C.T. Genetic and environmental epidemiology of Alzheimer's disease in arabs residing in Israel. J. Mol. Neurosci. 2003, 20:207-212.
13. Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie H., Huang Y., Jorm A., Mathers C., Menezes P.R., Rimmer E., Scazufca M. Global prevalence of dementia: a Delphi consensus study. Lancet 2005, 366:2112-2117.
14. Ganguli M., Chandra V., Kamboh M.I., Johnston J.M., Dodge H.H., Thelma B.K., Juyal R.C., Pandav R., Belle S.H., DeKosky S.T. Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. Arch. Neurol. 2000, 57:824-830.
15. Grant, W.B., 2001. Incidence of dementia and Alzheimer disease in Nigeria and the United States. JAMA 285, 2448 (author reply 2448-2449).
16. Green R.C., Cupples L.A., Kurz A., Auerbach S., Go R., Sadovnick D., Duara R., Kukull W.A., Chui H., Edeki T., Griffith P.A., Friedland R.P., Bachman D., Farrer L. Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch. Neurol. 2003, 60:753-759.
17. Gureje O., Ogunniyi A., Baiyewu O., Price B., Unverzagt F.W., Evans R.M., Smith-Gamble V., Lane K.A., Gao S., Hall K.S., Hendrie H.C., Murrell J.R. APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians. Ann. Neurol. 2006, 59:182-185.
18. Hachinski V., Iadecola C., Petersen R.C., Breteler M.M., Nyenhuis D.L., Black S.E., Powers W.J., DeCarli C., Merino J.G., Kalaria R.N., Vinters H.V., Holtzman D.M., Rosenberg G.A., Dichgans M., Marler J.R., Leblanc G.G. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006, 37:2220-2241.
19. Hall K., Hendrie H., Brittain H., Norton J.A. The development of a dementia screening interview in two distinct languages. Int. J. Methods Psychiatr. Res. 1993, 3:1-28.
20. Hall K., Ogunniyi A., Hendrie H., Osuntokun B.O., Hui S., Musick B., Rodenberg C.A., Unverzagt F., Gureje O., Baiyewu O. A cross-cultural community based study of dementias: methods and perfomance of the survey instrument Indianpolis, USA and Ibadan, Nigeria. Int. J. Methods Psychiatr. Res. 1996, 6:129-142.
21. Hall K.S., Gao S., Emsley C.L., Ogunniyi A.O., Morgan O., Hendrie H.C. Community screening interview for dementia (CSI 'D'); performance in five disparate study sites. Int. J. Geriatr. Psychiatry. 2000, 15:521-531.
22. Hall K., Murrell J., Ogunniyi A., Deeg M., Baiyewu O., Gao S., Gureje O., Dickens J., Evans R., Smith-Gamble V., Unverzagt F.W., Shen J., Hendrie H. Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba. Neurology 2006, 66:223-227.
23. Heckmann J.M., Low W.C., de Villiers C., Rutherfoord S., Vorster A., Rao H., Morris C.M., Ramesar R.S., Kalaria R.N. Novel presenilin 1 mutation with profound neurofibrillary pathology in an indigenous Southern African family with early-onset Alzheimer's disease. Brain 2004, 127:133-142.
24. Hendrie H.C., Hall K.S., Pillay N., Rodgers D., Prince C., Norton J., Brittain H., Nath A., Blue A., Kaufert J., et al. Alzheimer's disease is rare in Cree. Int. Psychogeriatr. 1993, 5:5-14.
25. Hendrie H.C., Osuntokun B.O., Hall K.S., Ogunniyi A.O., Hui S.L., Unverzagt F.W., Gureje O., Rodenberg C.A., Baiyewu O., Musick B.S. Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Am. J. Psychiatry 1995, 152:1485-1492.
26. Hendrie H.C., Ogunniyi A., Hall K.S., Baiyewu O., Unverzagt F.W., Gureje O., Gao S., Evans R.M., Ogunseyinde A.O., Adeyinka A.O., Musick B., Hui S.L. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA 2001, 285:739-747.
27. Hendrie H.C., Murrell J., Gao S., Unverzagt F.W., Ogunniyi A., Hall K.S. International studies in dementia with particular emphasis on populations of African origin. Alzheimer Dis. Assoc. Disord. 2006, 20:S42-S46.
28. Jorm A.F., Jacomb P.A. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol. Med. 1989, 19:1015-1022.
29. Kalaria R.N. The role of cerebral ischemia in Alzheimer's disease. Neurobiol. Aging 2000, 21:321-330.
30. Kalaria R.N. Dementia comes of age in the developing world. Lancet 2003, 361:888-889.
31. Kalaria R.N., Ballard C. Stroke and cognition. Curr. Atheroscler. Rep. 2001, 3:334-339.
32. Kalaria R.N., Ogeng'o J.A., Patel N.B., Sayi J.G., Kitinya J.N., Chande H.M., Matuja W.B., Mtui E.P., Kimani J.K., Premkumar D.R., Koss E., Gatere S., Friedland R.P. Evaluation of risk factors for Alzheimer's disease in elderly east Africans. Brain Res. Bull. 1997, 44:573-577.
33. Maj M., Janssen R., Satz P., Zaudig M., Starace F., Boor D., Sughondhabirom B., Bing E.G., Luabeya M.K., Ndetei D., et al. The World Health Organization's cross-cultural study on neuropsychiatric aspects of infection with the human immunodeficiency virus 1 (HIV-1). Preparation and pilot phase. Br. J. Psychiatry 1991, 159:351-356.
34. Mak Z., Kim J.M., Stewart R. Leg length, cognitive impairment and cognitive decline in an African-Caribbean population. Int. J. Geriatr. Psychiatry 2006, 21:266-272.
35. Morgan O.S., Eldemire D.A., Thesiger C.H., Luseko J., Sahota A., Gao S., Hall K.S., Hendrie H.C. APOE allele frequencies in demented and nondemented elderly Jamaicans. Ann. Neurol. 1998, 43:545.
36. Muriuki G. A History of the Kikuyu 1500-1900 1974, Oxford University Press, Nairobi, Kenya.
37. Ogunniyi A., Hall K.S., Gureje O., Baiyewu O., Gao S., Unverzagt F.W., Smith-Gamble V., Evans R.E., Dickens J., Musick B.S., Hendrie H.C. Risk factors for incident Alzheimer's disease in African Americans and Yoruba. Metab. Brain Dis. 2006, 21:235-240.
38. Osuntokun B.O., Hendrie H.C., Ogunniyi A.O., Hall K.S., Lekwauwa U.G., Brittain H.M., Norton J.A., Oyediran A.B., Pillay N., Rodgers D.D. Cross-cultural studies in Alzheimer's disease. Ethn. Dis. 1992, 2:352-357.
39. Osuntokun B.O., Sahota A., Ogunniyi A.O., Gureje O., Baiyewu O., Adeyinka A., Oluwole S.O., Komolafe O., Hall K.S., Unverzagt F.W., et al. Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians. Ann. Neurol. 1995, 38:463-465.
40. Pandav R.S., Chandra V., Dodge H.H., DeKosky S.T., Ganguli M. Hemoglobin levels and Alzheimer disease: an epidemiologic study in India. Am. J. Geriatr. Psychiatry 2004, 12:523-526.
41. Premkumar D.R., Cohen D.L., Hedera P., Friedland R.P., Kalaria R.N. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am. J. Pathol. 1996, 148:2083-2095.
42. Prince M., Acosta D., Chiu H., Scazufca M., Varghese M. Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet 2003, 361:909-917.
43. Prince M., Graham N., Brodaty H., Rimmer E., Varghese M., Chiu H., Acosta D., Scazufca M. Alzheimer Disease International's 10/66 Dementia Research Group - one model for action research in developing countries. Int. J. Geriatr. Psychiatry 2004, 19:178-181.
44. Prince M., Ferri C.P., Acosta D., Albanese E., Arizaga R., Dewey M., Gavrilova S.I., Guerra M., Huang Y., Jacob K.S., Krishnamoorthy E.S., McKeigue P., Rodrigues J.L., Salas A., Sosa A.L., Sousa R., Stewart R., Uwakwe R. The protocols for the 10/66 Dementia Research Group population-based research programme. BMC Public Health 2007, 7:165.
45. Richards S.S., Emsley C.L., Roberts J., Murray M.D., Hall K., Gao S., Hendrie H.C. The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of African-Americans. J. Am. Geriatr Soc. 2000, 48:1035-1041.
46. Romas S.N., Santana V., Williamson J., Ciappa A., Lee J.H., Rondon H.Z., Estevez P., Lantigua R., Medrano M., Torres M., Stern Y., Tycko B., Mayeux R. Familial Alzheimer disease among Caribbean Hispanics: a reexamination of its association with APOE. Arch. Neurol. 2002, 59:87-91.
47. Sayi J.G., Patel N.B., Premkumar D.R., Adem A., Winblad B., Matuja W.B., Mtui E.P., Gatere S., Friedland R.P., Koss E., Kalaria R.N. Apolipoprotein E polymorphism in elderly east Africans. East Afr. Med. J. 1997, 74:668-670.
48. Scacchi R., De Bernardini L., Mantuano E., Donini L.M., Vilardo T., Corbo R.M. Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer's disease (AD), mixed dementia and vascular dementia: lack of association of epsilon 4 allele with AD in Italian octogenarian patients. Neurosci. Lett. 1995, 201:231-234.
49. Stewart R., Russ C., Richards M., Brayne C., Lovestone S., Mann A. Apolipoprotein E genotype, vascular risk and early cognitive impairment in an African Caribbean population. Dement. Geriatr. Cogn. Disord. 2001, 12:251-256.
50. WHO, 1984. The use of epidemiology in the study of the elderly. Report of a WHO Scientific Group on the Epidemiology of Aging. WHO Techn. Rep. Ser. 707, 9.
51. WHO, 2002. Active ageing: a policy framework, 2002 health report. World Health Organisation, Geneva.
52. Wimo A., Jonsson L., Winblad B. An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement. Geriatr. Cogn Disord. 2006, 21:175-181.
53. Yang M., Hendrie H.C., Hall K.S., Oluwole O.S., Hodes M.E., Sahota A. Improved procedure for eluting DNA from dried blood spots. Clin. Chem. 1996, 42:1115-1116.